Frontiers in Immunology (Feb 2020)
Corrigendum: Natural Killer Cell-Derived Exosomal miR-3607-3p Inhibits Pancreatic Cancer Progression by Targeting IL-26
- Hongwei Sun,
- Keqing Shi,
- Kai Qi,
- Hongru Kong,
- Jie Zhang,
- Shengjie Dai,
- Wen Ye,
- Tuo Deng,
- Qiye He,
- Qiye He,
- Mengtao Zhou
Affiliations
- Hongwei Sun
- Department of Hepatobiliary Surgery, Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Keqing Shi
- Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, Center of Precision Medicine, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Kai Qi
- Shanghai Institute of Nutrition and Health, Chinese Academy of Sciences, Shanghai, China
- Hongru Kong
- Department of Hepatobiliary Surgery, Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Jie Zhang
- Department of Hepatobiliary Surgery, Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Shengjie Dai
- Department of Hepatobiliary Surgery, Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Wen Ye
- Department of Hepatobiliary Surgery, Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Tuo Deng
- Department of Hepatobiliary Surgery, Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- Qiye He
- Singlera Genomics Inc., San Diego, CA, United States
- Qiye He
- Singlera Genomics (Shanghai) Ltd., Shanghai, China
- Mengtao Zhou
- Key Laboratory of Diagnosis and Treatment of Severe Hepato-Pancreatic Diseases of ZheJiang Province, Precision Medical Center Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, China
- DOI
- https://doi.org/10.3389/fimmu.2020.00277
- Journal volume & issue
-
Vol. 11
Abstract
No abstracts available.Keywords
